Twenty-six percent of the 2,136 patients were women. Although women were an average of 4.5 years older than the male patients and had more cardiovascular risk factors and more severe angina than did the men, their anatomic coronary artery disease was not more extensive. The clinical success rate of PTCA was 79% for both women and men.
Women had more initial complications (29% versus 20%, p<0.001) and a considerably higher procedural mortality rate (2.6% versus 0.3%, p<0.001).
For patients who survived the initial procedure, 4-year survival was not different for men and women. Women had slightly fewer events (myocardial infarction, repeat PTCA, and/or coronary artery bypass grafting) but were much more likely to report angina and medication use 4 years after initial PTCA. Associations between low cholesterol levels and other markers of disease were explored in 5,201 elderly men and women. Cholesterol levels < 160 mg/dl were present in 11.6% of men and 3.7% of women. After adjustment for age, low cholesterol levels were associated with a twofold increased prevalence of diabetes and with lower levels of lipoproteins, hemoglobin, albumin, and factor VII, suggesting a link with hepatic synthetic function. On multivariate analysis, factors most strongly associated with low cholesterol were decreased factor VII levels, decreased albumin, and diabetes. Cross-sectional associations with low cholesterol differ by sex and suggest poorer health by some measures. Quantitative operator-independent measurements of the reflectivity of myocardial wall in 38 young patients with f-thalassemia major, without signs of myocardial dysfunction, and 20 age-and sexmatched controls were obtained by means of an on-line analysis of the ultrasonic radiofrequency signal. The integrated values of the radiofrequency ultrasound signal were normalized for the pericardial interface in each subject and expressed in percent (IB%). Thalassemic patients had been under transfusion therapy for 16±5 years and had received 313±138 transfusion units; they all had been under chelation treatment (desferroxiamine) for 9±2 years. The IB% values were higher in patients with thalassemia major than in controls for both septum (35±14% versus 21±6%, p<0.001) and posterior wall (16±6% versus 11±3%, p<0.001). In conclusion, our data demonstrate that myocardial reflectivity is abnormally increased in patients with thalassemia major under transfusion treatment, probably due to myocardial iron deposits and/or secondary structural changes, even when no signs of myocardial functional involvement are apparent. To define the relation between left ventricular dilatation and dysfunction and to identify early predictors of chronic heart failure, left ventricular volumes and regional area shrinkage fraction (gated single photon emission computed tomography) and hemodynamics at rest and during exercise were assessed prospectively 4 days, 4 weeks, 6 months, and 1.5 and 3 years after first myocardial infarction. Patients without dilatation (n = 38) maintained stable volumes and hemodynamics. In 26% (n = 18), limited dilatation developed within 4 weeks, restoring depressed stroke volume thereafter. Wedge pressure during exercise, however, rose progres-sively. In 20% (n= 14), progressive dilatation developed. Depressed performance was also restored by 4 weeks but progressively deteriorated thereafter. Area shrinkage fraction in normokinetic sectors at 4 days deteriorated progressively after 4 weeks, but hypokinetic and dyskinetic sectors remained unchanged. Global ejection fraction fell after 1.5 years, whereas right atrial pressure, wedge pressure, and systemic vascular resistance increased. Early predictors (multivariate analysis) of dysfunction and remodeling were ejection fraction and stroke index at 4 days, infarct size, infarct location, and TIMI grade of infarct artery perfusion. We postulated that the outcome of electropharmacological studies would be modulated by the patency of the infarct-related artery (IRA). Sixtyfour consecutive patients with remote myocardial infarction and spontaneous and inducible ventricular tachyarrhythmias were studied. Sixteen patients (25%) responded to antiarrhythmic drug therapy. A patent IRA was associated with antiar-rhythmic drug response significantly more frequently than was an occluded IRA (45% versus 9%, p=0.001). The presence of a patent IRA was the only independent predictor of antiarrhythmic drug response. The use of IRA patency for the prediction of successful electropharmacological studies has a balanced sensitivity and specificity of 81% and 67%, respectively. Body Surface Potential Mapping of ST Segment Changes In Acute Myocardlal Infarction: Implications for ECG Enrollment Criteria for Thrombolytic Therapy .. 773 Analysis of body surface potential maps identifies areas on the torso where the most significant ST changes most frequently occur in acute MI. Two leads originating from areas where ST depression and ST elevation, respectively, departed most significantly from normal values achieve optimal classification in each of three MI classes: anterior, inferior, and posterior MI. Five of these six leads are outside the standard precordial lead positions.
Epidemiology of Low Cholesterol Levels

Myocardial Infarction
ST depression is the most potent discriminator for each MI group and contains information independent from ST elevation. Quantitative analysis of ST magnitude at each electrode site allows determination of best site-specific thresholds for ECG criteria. Appropriate selection of ECG leads and measurements may help remove inconsistencies in present ECG selection criteria and improve comparability of treatment results. Isoproterenol was administered to 25 patients with hemodynamically stable sustained monomorphic ventricular tachycardia (VT) in the drug-free state and then after intravenous procainamide or oral quinidine therapy. In patients with readily inducible VT, isoproterenol 1) decreased VT cycle length more during procainamide and quinidine therapy than in the drug-free state, 2) deceased QRS duration (conduction) more during procainamide and quinidine therapy than in the drug-free state, 3) decreased right ventricular refractoriness by the same amount before and during procainamide and quinidine drug therapy, and 4) did not alter the number of extrastimuli required for VT induction. To the extent that QRS duration reflects changes in conduction within the VT circuit, these results imply that the attenuation of drug-induced slowing of VT by isoproterenol is due primarily to changes in conduction rather than refractoriness. Thirty-six patients were prospectively randomized to receive either angioplasty (20 patients) or surgery (16 patients) as treatment for unoperated coarctation of the aorta. Reduction in peak systolic pressure gradient across the coarctation was similar (86%) immediately after both balloon coarctation angioplasty and surgery. Aneurysms were seen in the angioplasty group (20%) but not the surgery group (0%). The incidence of other complications was similar in both groups, although two patients experienced neurological complications after surgery. The incidence of restenosis tended to be greater in the angioplasty group (25%) than the surgery group (6%). Although the risk of aneurysm formation after angioplasty is higher than after surgery, balloon coarctation angioplasty of unoperated coarctation of the aorta may provide an effective initial alternative to surgical repair in many patients. This collaborative, international study was performed to evaluate the current uses of implantable cardioverter-defibrillators (ICD) in young patients (less than 20 years of age) and their subsequent clinical outcome. Detailed information was obtained regarding 125 patients, 76% of whom had been resuscitated from sudden cardiac death. The predominant forms of associated cardiovascular disease were cardiomyopathy (56%), primary electrical disease (26%), and congenital heart disease (18%). During a mean follow-up of 31 months, at least one appropriate ICD discharge was reported in 59% of the patients. Duration of follow-up greater than 24 months was the primary correlate of ICD discharge (p=0.001). Nine patients died during follow-up, with impaired ventricular function the primary correlate of mortality (p=0.002).
Comparison of Angioplasty and Surgery for Unoperated Coarctation of the Aorta
Sudden Cardiac
Despite the differing substrates of cardiovascular disease, patterns of ICD use in young patient are similar to those of adults. Thus, use of these devices in young survivors of SCD appears valid. The sensitivity and specificity of signal-averaged ECG using a 28-lead optimal array were compared with an orthogonal array in 223 patients with prior myocardial infarctions (82 with inducible VT). From the optimal array, 28 QRS durations were obtained, each defined as the duration from the earliest onset of any leads to the offset of that lead. QRS duration > 120 msec in 23 leads were considered abnormal. While the specificity of each array was comparable (84%), the optimal array (70%) was more sensitive than the orthogonal array when analyzed either as a combined vector magnitude (54%,p=0.001) or as three individual leads (59%, p=0.004). The increase in sensitivity was equal for anterior (n= 120) and inferior (n= 103) infarctions. Application of the 28-lead optimal array improves the sensitivity of signal-averaged ECG without loss of specificity.
A Population Study of the Natural History of Wolff-Parkinson-White Syndrome in Olmsted County, Minnesota, 1953 Minnesota, -1989 The interaction between 5-hydroxytryptamine (5-HT) and thromboxane A2 (TXA2) was assessed in human epicardial coronary arteries. In the presence of the 5 -HT2 receptor antagonist ketanserin, the contractile response of 5-HT could be significantly enhanced by the presence of either the EC30 or EC50 concentrations of the thromboxane mimetic U46619. This potentiation was inhibited by methiothepin, a nonselective 5-HT-like/5-HT2 receptor antagonist. These data indicate that a synergistic interaction may occur between U46619 and 5-HT acting specifically at 5-HT1-like receptors. To test the hypothesis that preconditioning reduces infarct size by depleting cardiac glycogen stores and attenuating the degree of intracellular acidosis during subsequent prolonged left coronary artery (LCA) occlusion, preconditioned and control rats were subjected to 45 minutes of LCA occlusion and 120 minutes of reflow immediately after preconditioning or after 30 minutes, 1 hour, or 6 hours of nonischemic recovery after preconditioning. Compared with controls, preconditioned rats demonstrated marked glycogen depletion in the ischemic region, attenuation of intracellular acidosis during ischemia, and marked infarct size reduction. In rats allowed to recover after preconditioning, the time course of glycogen recovery paralleled the loss of protection from ischemic injury. We conclude that glycogen depletion and the attenuation of intracellular acidosis during ischemia appear to be important factors in delaying irreversible injury and reducing infarct size in this animal model of myocardial preconditioning. One or more brief episodes of coronary artery occlusion "precondition" the myocardium perfused by that artery and limit infarct size caused by a subsequent period of sustained ischemia. We used A39 the anesthetized canine model to determine whether preconditioning protects only those myocytes subjected to brief ischemia or whether brief occlusions in one vascular bed also protects remote virgin myocardium from subsequent coronary occlusion. Infarct size produced by 60 minutes of left anterior descending coronary artery occlusion was significantly smaller in dogs that underwent four episodes of 5 minutes of circumflex branch occlu-sion plus 5 minutes of reperfusion before the sustained left anterior descending coronary artery occlusion compared with controls. Thus, the benefits of preconditioning are not limited to those myocytes subjected to brief ischemia: Brief coronary occlusion in one vascular bed also protects remote myocardium from subsequent sustained ischemia. Light and electron microscopic immunohistochemical methods using specific (OX 6 and W3/25) monoclonal antibodies were used to investigate the changes that interstitial dendritic cells (IDCs) of the heart undergo in myocardial infarction. The numbers of OX 6-positive IDCs per mm2 were 82±10 in the left ventricle of unoperated rats. IDCs in the border zone of myocardial infarction were markedly increased (796±79, 528±98, and 159±15 at 7, 14, and 21 days, respectively) and were associated with clusters of T-helper lymphocytes. These findings suggest that interstitial dendritic cells participate in the activation of lymphocytes and in the initiation of immune responses in myocardial infarction. The development of volume overload-induced right ventricular hypertrophy and left ventricular (LV) eccentric hypertrophy (i.e., increased LV volume and decreased wall thickness/radius ratio) was associated with significant increases in plasma and cardiac renin activity shortly after induction of an aortocaval shunt. Although chronic treatment with either enalapril or losartan similarly lowered LV end-diastolic pressure, only losartan but not enalapril significantly attenuated the hypertrophic responses of the heart. These results appear to reflect other than hemodynamical determinants of the hypertrophic response to cardiac volume overload.
Effect of Selective Angiotensin 11 Receptor Antagonism and Angiotensin
Converting Enzyme Inhibition on the Coronary Vasculature In Vivo: Intravascular Two-dimensional and Doppler Ultrasound Studies We examined the effects of an AT,-receptor antagonist Losartan on coronary arteries in dogs, using intravascular ultrasound. At peak effect, Losartan increased coronary cross-sectional area and average peak velocity, resulting in an increase in coronary blood flow. The maximal effect of Losartan on coronary blood flow was significantly greater than that of Enalaprilat. Relative to adenosine (6 mg i.c.), flow increase from baseline was 0.37 with the AT,-receptor antagonist and 0.19 with the angiotensin converting enzyme inhibitor. Losartan-induced epicardial vasodilation was partially inhibited by L-NAME. These acute canine studies suggest that inhibition of AT,-receptors in the coronary circulation results in vasodilator responses greater in magnitude than angiotensin converting enzyme inhibition and partly endothelium dependent.
A40
Cholinergic 939 We studied the mechanisms of cocaine-induced coronary vasoconstriction in 10 conscious, chronically instrumented dogs. We observed a 24±3% (p<0.05) increase in calculated coronary vascular resistance, whereas coronary blood flow increased by 13±3% (p<0.05), to meet the 41±9% (p<0.05) increase in measured myocardial oxygen consumption associated with cocaine administration (1 mg/ kg). Importantly, we observed that cholinergic blockade significantly attenuated the coronary vasoconstrictor response to cocaine in both the pres-ence and absence of a-blockade. Combined a-, f3-, and cholinergic blockade abolished the vasoconstrictor effects. Of note, cocaine administration was associated with increased myocardial oxygen delivery achieved through a significant increase in arterial oxygen content (control value, 15±0.6 vol%; peak value, 17.8±0.5 vol%; p<0.05). Thus, the effects of cocaine on the coronary circulation are the sum of increased metabolic demand and adrenergic vasoconstriction, which is modulated significantly by parasympathetic tone. To test the hypothesis that induction of the heatshock response delays the progression of myocyte injury, rabbits were initially pretreated with wholebody hyperthermia and then subjected to acute regional ischemia and coronary reperfusion either 24 or 40 hours later. Infarct area (tetrazolium staining) was normalized to anatomic risk area (microsphere autoradiography). Western blot analysis of ventricular tissue biopsies from both ischemic and nonischemic myocardium indicated expression of HSP71 in heat-shocked rabbits. Infarct size was significantly reduced at 24 but not 40 hours after heat shock in rabbits undergoing 30 minutes of regional ischemia with 3 hours of reperfusion compared with control rabbits. Myocyte injury was not reduced when the duration of ischemia was increased to 45 minutes in rabbits treated with whole-body hyperthermia and 40 hours of recovery. These findings suggest that whole-body hyperthermia delays the onset of irreversible myocyte injury in this animal model of acute myocardial infarction. We determined whether the beneficial effects of carnitine in ischemic hearts was accompanied by a stimulation in glucose use. Isolated working rat hearts were perfused under aerobic conditions with 11 mM glucose, 1.2 mM palmitate, and 100 1U/ml insulin and then subjected to a period of global ischemia followed by aerobic reperfusion. Myocardial carnitine content was first increased by perfusing hearts with 10 mM carnitine for a period of 60 minutes. This resulted in a twofold increase in total myocardial carnitine content. Glycolysis rates in carnitine-treated hearts were not significantly altered compared with control hearts, whereas glu-cose oxidation rates were increased approximately threefold compared with control hearts. During reperfusion of ischemic hearts, glycolysis rates returned to preischemic values in both control and treated hearts. Glucose oxidation rates also recovered to preischemic values in these hearts and remained significantly higher in carnitine-treated hearts. In these hearts, recovery of mechanical function was 71% of preischemic values compared with 44% in control hearts. This suggests that the beneficial effects of carnitine in ischemia can be explained by a stimulation in glucose oxidation. Coronary blood flow, fractional shortening, and the lactate extraction ratio were measured with and without administration of human recombinant superoxide dismutase before and after an injection of microspheres into the coronary artery in 78 dogs. Pretreatment with superoxide dismutase increased coronary blood flow by enhancement of the release of adenosine. The enhancement of coronary blood flow and adenosine release, which are associated with the restoration of 5'-nucleotidase activity, attenuated the contractile and metabolic dysfunc-tion. Administration of superoxide dismutase at 10 and 30 minutes but not at 60 minutes after coronary embolization restored both contractile and metabolic dysfunction. This restoration of the contractile and metabolic dysfunction was blunted by 8-phenyltheophylline and coronary submaximal vasodilation induced by papaverine and adenosine. We conclude that superoxide dismutase restores the ischemic injury in coronary microembolization by preservation of 5'-nucleotidase activity and augmentation of adenosine production. The relative immunogenicity and thrombolytic properties toward arterial and venous thrombi of streptokinase and recombinant staphylokinase were studied in baboons. Baboon plasma contained streptokinase-neutralizing activity (neutralizing 0.39±0.25 ,ug streptokinase per milliliter of plasma) that increased to 4.4±4.6 ,ug/ml after 4 weekly administrations of 0.30 mg/kg streptokinase and was associated with marked allergic reactions and partial resistance to lysis of a blood clot inserted into an extracorporeal loop. Staphylokinase-neutralizing antibodies could not be detected at baseline or after five repeated administrations of recombinant staphylokinase in three of four animals, and resistance to renewed administration did not occur. Staphylokinase had a thrombolytic potency toward jugular vein blood clots similar to that of streptokinase (50% lysis of a`PI-fibrin-labeled clot requiring 0.140 mg/kg [3.25 nmol/kg] streptokinase and 0.058 mg/kg [3.22 nmol/kg] recombinant staphylokinase) but had a higher thrombolytic potency toward platelet-rich femoral arterial eversion graft thrombi, as evidenced by more frequent and more persistent recanalization (p<0.05). Clot targeting of recombinant single-chain urokinase-type plasminogen activator (rscu-PA) with fibrin-specific monoclonal antibodies was found to enhance its thrombolytic potency toward experimental pulmonary emboli in hamsters 40-60-fold. The thrombolytic potency of rscu-PA/antifibrin conjugates was determined by their clearance, rate, and extent of initial binding to the emboli as well as by changes in binding during clot lysis. Clot targeting with fibrin-specific antibodies did not increase the maximal rate of clot lysis or shorten the mini-mal lag phase of clot lysis; these parameters were indeed very similar to those obtained with rscu-PA or with recombinant tissue-type plasminogen activator (rt-PA). Thus, clot targeting reduces the dose required to obtain maximal clot lysis, but the minimal lag-phase and the maximal rate of lysis are independent of the nature of the plasminogen activator or of targeting. These observations suggest that there may be intrinsic limitations to the maximal achievable speed of thrombolysis. This study demonstrates that dietary w-3 fatty acids are rapidly incorporated into blood and vascular tissues, modestly reduce the thrombotic responses of flowing blood to thrombogenic surfaces, and interrupt both the thrombotic and proliferative responses at sites of mechanical vascular injury without significantly impairing hemostatic function or producing other adverse effects when administered to baboons.
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